메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 33, Issue 22, 2015, Pages 2481-
Is there any true association between BRAF V600E mutation and recurrence, particularly in low-risk, papillary thyroid cancer?
Author keywords

[No Author keywords available]
Indexed keywords

FLUORODEOXYGLUCOSE F 18; THYROGLOBULIN; B RAF KINASE;
EID: 84940380341     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.60.0999     Document Type: Letter
Times cited : (5)
References (6)
  • 1
    • 84920593838 scopus 로고    scopus 로고
    • Association between BRAF V600E mutation and recurrence of papillary thyroid cancer
    • Xing M, Alzahrani AS, Carson KA, et al: Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. J Clin Oncol 33:42-50, 2015
    • (2015) J Clin Oncol , vol.33 , pp. 42-50
    • Xing, M.1    Alzahrani, A.S.2    Carson, K.A.3
  • 2
    • 84940397570 scopus 로고    scopus 로고
    • Atlanta, GA, American Cancer Society
    • When Cancer Comes Back: Cancer Recurrence. Atlanta, GA, American Cancer Society. http://www.cancer.org/acs/groups/cid/documents/webcontent/002947-pdf.pdf
    • When Cancer Comes Back: Cancer Recurrence
  • 3
    • 70349093388 scopus 로고    scopus 로고
    • Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal
    • Elisei R, Schlumberger M, Driedger J, et al: Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal. J Clin Endocrinol Metab 94:4171-4179, 2009
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 4171-4179
    • Elisei, R.1    Schlumberger, M.2    Driedger, J.3
  • 4
    • 78649701492 scopus 로고    scopus 로고
    • Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: Using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system
    • Tuttle RM, Tala H, Shah J, et al: Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: Using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 20:1341-1349, 2010
    • (2010) Thyroid , vol.20 , pp. 1341-1349
    • Tuttle, R.M.1    Tala, H.2    Shah, J.3
  • 5
    • 84860479650 scopus 로고    scopus 로고
    • Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients
    • Schvartz C, Bonnetain F, Dabakuyo S, et al: Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients. J Clin Endocrinol Metab 97:1526-1535, 2012
    • (2012) J Clin Endocrinol Metab , vol.97 , pp. 1526-1535
    • Schvartz, C.1    Bonnetain, F.2    Dabakuyo, S.3
  • 6
    • 84857912523 scopus 로고    scopus 로고
    • Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation
    • Vianello F, Mazzarotto R, Mian C, et al: Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation. Clin Oncol (R Coll Radiol) 24:162-168, 2012
    • (2012) Clin Oncol (R Coll Radiol) , vol.24 , pp. 162-168
    • Vianello, F.1    Mazzarotto, R.2    Mian, C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.